B-Cell Lymphoma Drug Receives FDA Priority Review
ADC Therapeutic’s Biologics License was approved by the U.S. Food and Drug Administration (FDA) for their relapsed/refractory diffuse large B-cell Lymphoma drug candidate. The antibody conjugate drug, that catalyzes cancer cell death is being investigated in a...
Phase 3 Trial of Johnson & Johnson COVID-19 Vaccine Underway in Spain
The Agency for Medicines and Health Products, the Spanish health regulator, has just approved the trial of the second segment of Phase 3 for Johnson & Johnson COVID-19 vaccine in 9 hospitals across the country. The New Brunswick based...
At-Home COVID-19 Test Gets FDA Emergency Use Authorization
Lucira Health, a California based company, has just received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA) for its fully-at-home COVID-19 diagnostic test. It will be available on a national level in Spring of 2021...
Moderna COVID-19 Vaccine Candidate Shows 95% Efficacy Rate
Based on long-term data from a late-stage trial including 30,000 participants, Moderna’s COVID-19 vaccine candidate has shown results of a 95% efficacy rate in fighting the virus. Moderna is planning to file for Emergency Use Authorization (EUA) in the coming...
Novum IQ Infusion Platform Gains Marketing Approval from Health Canada
Baxter Canada is increasing their product line in the realm of medication delivery and management with Novum IQ large volume syringe pumps, as they have just received marketing approval. The medical device uses new infusion protection...
Russia Announces Interim Results, Show Sputnik-V is 92% Effective in COVID-19 Protection
As Russian drug-makers surge to keep pace with Western pharma companies in the race for a COVID-19 vaccine, Russia has derived results from a late stage human trial on their own candidate, Sputnik-V. Their sample size of 20 participants was far smaller than...